Related Experiment Video

Updated: Jul 19, 2026

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats
07:17

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats

Published on: January 19, 2024

Vagus nerve stimulation for intractable seizures in children

Russell P Saneto1, Marcio A Sotero de Menezes, Jeffrey G Ojemann

  • 1Division of Pediatric Neurology, Children's Hospital and Regional Medical Center/University of Washington, Seattle, WA 98105, USA. russ.saneto@seattlechildrens.org

Pediatric Neurology
|November 1, 2006
PubMed

Insights

Vagus nerve stimulation effectively reduced intractable seizures in children under 12. This treatment showed a median 55% seizure reduction, offering significant improvement for medically refractory epilepsy.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Treatment
  • Neuromodulation

Background:

  • Intractable seizures in children pose significant challenges.
  • Limited treatment options exist for medically refractory epilepsy in pediatric populations.
  • Vagus nerve stimulation (VNS) is an established neuromodulation therapy.

Purpose of the Study:

  • To evaluate the efficacy of vagus nerve stimulation (VNS) in children under 12 with intractable seizures.
  • To assess the impact of VNS on seizure frequency and severity in this pediatric cohort.
  • To determine the effectiveness of VNS across different seizure types.

Main Methods:

  • A cohort of 43 children under 12 years with intractable seizures received vagus nerve stimulation.
  • Patients were monitored for varying durations: <12 months (n=5), 12-17 months (n=16), and >=18 months (n=22).
  • Seizure reduction was the primary outcome measure.

Main Results:

  • An overall median seizure reduction of 55% was observed.
  • Thirty-seven percent of children experienced at least a 90% reduction in seizures.
  • Vagus nerve stimulation demonstrated effectiveness in children with generalized, mixed, and partial medically refractory seizures.

Conclusions:

  • Vagus nerve stimulation is an effective treatment for intractable seizures in children under 12.
  • VNS provides significant seizure reduction across various epilepsy types in pediatric patients.
  • This neuromodulation therapy offers a viable option for medically refractory epilepsy in children.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats09:39

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats

Published on: July 14, 2020

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...